Detalles de la búsqueda
1.
Creation of a gene expression classifier for predicting Parkinson's disease rate of progression.
J Neural Transm (Vienna)
; 127(5): 755-762, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32385576
2.
Effects of novel neuroprotective and neurorestorative multifunctional drugs on iron chelation and glucose metabolism.
J Neural Transm (Vienna)
; 120(1): 37-48, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22446839
3.
The novel multifunctional, iron-chelating drugs M30 and HLA20 protect pancreatic beta-cell lines from oxidative stress damage.
J Pharmacol Exp Ther
; 333(3): 874-82, 2010 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-20237072
4.
The novel multitarget iron chelating and propargylamine drug M30 affects APP regulation and processing activities in Alzheimer's disease models.
Neuropharmacology
; 123: 359-367, 2017 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28571715
5.
Neuroprotective and neurorestorative activities of a novel iron chelator-brain selective monoamine oxidase-A/monoamine oxidase-B inhibitor in animal models of Parkinson's disease and aging.
Neurobiol Aging
; 36(3): 1529-42, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25499799
6.
Molecular targets of the multifunctional iron-chelating drug, M30, in the brains of mouse models of type 2 diabetes mellitus.
Br J Pharmacol
; 171(24): 5636-49, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25073425
7.
The novel multi-target iron chelator, M30 modulates HIF-1α-related glycolytic genes and insulin signaling pathway in the frontal cortex of APP/PS1 Alzheimer's disease mice.
Curr Alzheimer Res
; 11(2): 119-27, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24359498
Resultados
1 -
7
de 7
1
Próxima >
>>